Consistently, in a mouse liver metastasis model, combination of radiotherapy and anti-CD25/CTLA-4 antibody therapy increased tumor CD8+ T-cell accumulation with concurrent decrease of tumor Tregs, suppressed locally irradiated and abscopal unirradiated tumor growth, and improved overall survival rate. This evidence concerns the gene CTLA4 and neoplasm.